Pancreatic Cancer Research

Preprint2026

Global dissemination of FC- ϵ RI and p53 signalling perturbation contribute to Dasatinib resistance in Pancreatic Cancer Cell-lines

Published
23 February 2026
Citations
0
Type
Preprint

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try